...
首页> 外文期刊>The Journal of Pharmacology and Experimental Therapeutics: Official Publication of the American Society for Pharmacology and Experimental Therapeutics >Neurokinin A-induced vasoconstriction and muscular contraction in the rat isolated stomach: mediation by distinct and unusual neurokinin2 receptors.
【24h】

Neurokinin A-induced vasoconstriction and muscular contraction in the rat isolated stomach: mediation by distinct and unusual neurokinin2 receptors.

机译:神经激肽A诱导的大鼠离体胃部血管收缩和肌肉收缩:由独特和异常的神经激肽2受体介导。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

This study examined the pharmacological identity of the tachykinin receptors which in the rat stomach mediate vasoconstriction and muscular contraction. The vasculature of the rat isolated stomach was perfused with oxygenated Krebs buffer containing 3% dextran. Vasoconstrictor responses were recorded as increases in the vascular perfusion pressure and gastric contractions were measured as increases in the intraluminal pressure. By examining the effects of selective agonists and antagonists for tachykinin neurokinin (NK)1, NK2 and NK3 receptors it was found that the vasculature contained only NK2 receptors that were activated by the NK2 receptor agonist [betaAla8]-NKA-(4-10) and inhibited by the NK2 receptor antagonists MEN-10,627 and GR-94,800. However, the vasoconstrictor action of NKA was blocked only when the preparations were exposed to a combination of NK1, NK2 and NK3 receptor antagonists (SR-140,333, MEN-10,627, PD-161,182). In contrast, the NKA-evoked contraction of the gastric musculature was suppressed by NK2 receptor antagonists but little affected by NK1 or NK3 receptor antagonists. This observation was consistent with the predominance of NK2 receptors on the muscle as revealed by the effects of receptor-selective NK1, NK2 and NK3 agonists and antagonists. These results demonstrate that the major tachykinin receptor type present on the gastric vasculature and musculature is a NK2 receptor that is sensitive to receptor-selective agonists and antagonists. The NKA-evoked gastric contraction is also primarily due to NK2 receptor activation, whereas the NKA-induced vasoconstriction is mediated by a distinct and unusual type of NK2-like receptor that is blocked by a combination of NK1, NK2 and NK3 receptor antagonists only.
机译:这项研究检查了速激肽受体的药理学特性,它在大鼠胃中介导血管收缩和肌肉收缩。用含3%葡聚糖的含氧Krebs缓冲液灌注大鼠离体胃的血管。血管收缩反应被记录为血管灌注压力增加,胃收缩被测量为腔内压力增加。通过检查速激肽神经激肽(NK)1,NK2和NK3受体的选择性激动剂和拮抗剂的作用,发现脉管系统仅包含被NK2受体激动剂[betaAla8] -NKA-(4-10)激活的NK2受体。并被NK2受体拮抗剂MEN-10,627和GR-94,800抑制。但是,仅当将制剂暴露于NK1,NK2和NK3受体拮抗剂(SR-140,333,MEN-10,627,PD-161,182)的组合中时,才能阻止NKA的血管收缩作用。相反,NK2受体拮抗剂抑制了NKA引起的胃肌肉收缩,而NK1或NK3受体拮抗剂的影响很小。如受体选择性NK1,NK2和NK3激动剂和拮抗剂的作用所揭示,该观察结果与肌肉上NK2受体的优势一致。这些结果表明,存在于胃血管和肌肉组织上的主要速激肽受体类型是对受体选择性激动剂和拮抗剂敏感的NK2受体。 NKA引起的胃收缩也主要归因于NK2受体激活,而NKA诱导的血管收缩是由独特且异常的NK2类受体介导的,后者仅被NK1,NK2和NK3受体拮抗剂的组合所阻断。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号